Walgreens Boots Alliance

Walgreens Boots Alliance Reports Fiscal 2024 Second Quarter Results

Retrieved on: 
Thursday, March 28, 2024
Retail, Health, Discount, Variety, Convenience Store, Specialty, Pharmaceutical, EPS, Loss, Operating cost, Capital expenditure, Walgreens, Sale, Growth, WBA, Pharmacy, Walgreens Boots Alliance, Bank

Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced financial results for the second quarter of fiscal 2024, which ended February 29, 2024.

Key Points: 
  • Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced financial results for the second quarter of fiscal 2024, which ended February 29, 2024.
  • Second quarter operating loss was $13.2 billion compared to an operating income of $197 million in the year-ago quarter.
  • Net loss in the second quarter was $5.9 billion compared to net earnings of $703 million in the year-ago quarter, reflecting non-cash impairment charges.
  • Loss per share in the second quarter was $6.85 compared to earnings per share of $0.81 in the year-ago quarter.

Telehealth Pioneer Paul Johnson Joins DeepX Health Advisory Board

Retrieved on: 
Tuesday, April 2, 2024
Diagnosis, 23andMe, Skin cancer, LloydsPharmacy, Business, Health, Acquisition, University, Silicon, Walgreens Boots Alliance, Pharmaceutical industry

WASHINGTON, April 2, 2024 /PRNewswire-PRWeb/ -- DeepX Health is pleased to announce the appointment of Paul Johnson to its advisory board. Mr. Johnson brings a wealth of experience in the healthcare and technology sectors, with a proven track record of building and scaling innovative healthcare businesses.

Key Points: 
  • DeepX Health appoints healthcare industry veteran Paul Johnson to its advisory board to leverage his experience in scaling healthcare businesses.
  • WASHINGTON, April 2, 2024 /PRNewswire-PRWeb/ -- DeepX Health is pleased to announce the appointment of Paul Johnson to its advisory board.
  • Mr. Johnson was the founder and CEO of Lemonaid Health, a pioneering online healthcare company that he successfully led through an acquisition by 23andMe.
  • "As a new advisory board member, I'm excited to join DeepX Health, one of the pioneers in AI-driven cancer diagnostics," said Paul Johnson.

Walgreens Boots Alliance Schedules Fiscal 2024 Second Quarter Earnings Announcement for March 28

Retrieved on: 
Monday, March 4, 2024
General Health, Health, Retail, Pharmaceutical, Specialty, WBA, Walgreens Boots Alliance

Walgreens Boots Alliance, Inc. (Nasdaq: WBA) will release its fiscal 2024 second quarter results at 7 a.m.

Key Points: 
  • Walgreens Boots Alliance, Inc. (Nasdaq: WBA) will release its fiscal 2024 second quarter results at 7 a.m.
  • ET on Thursday, March 28, 2024, followed by a one-hour conference call with WBA management beginning at 8:30 a.m.
  • The conference call will be simulcast through the WBA investor relations website at: http://investor.walgreensbootsalliance.com .
  • A replay will be archived on the website for 12 months after the call.

Walgreens Boots Alliance Names Lanesha Minnix Executive Vice President and Global Chief Legal Officer

Retrieved on: 
Monday, February 26, 2024
Legal, Pharmaceutical, General Health, Health, Specialty, Professional Services, Discount, Variety, Retail, University, Pharmacy, EVP, Multimedia, ELC, Marketing, Shell USA, MBA, WBA, Executive Committee, K&L Gates, Ecolab, Walgreens Boots Alliance, Saint Louis University, ABM Industries, Flowserve, Management

Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today named Lanesha Minnix the company’s executive vice president (EVP) and global chief legal officer.

Key Points: 
  • Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today named Lanesha Minnix the company’s executive vice president (EVP) and global chief legal officer.
  • View the full release here: https://www.businesswire.com/news/home/20240226589815/en/
    Lanesha Minnix named global chief legal officer, Walgreens Boots Alliance (Photo: Business Wire)
    Minnix, who will report to WBA CEO Tim Wentworth and serve on his Executive Committee, will oversee the company’s global legal, compliance, corporate governance and corporate security functions.
  • “Lanesha is a widely respected leader and legal expert, and we are thrilled to welcome her to WBA in this important role,” said Wentworth.
  • Earlier this month, the company announced the appointment of Manmohan Mahajan as EVP and global chief financial officer, Elizabeth Burger as EVP and chief human resources officer and Mary Langowski as EVP and president, U.S. Healthcare.

United Airlines Names Rosalind Brewer to Board of Directors

Retrieved on: 
Wednesday, February 28, 2024
Pharmacy, UAL, Spelman College, Starbucks, Education, Walgreens, Club, Health, COVID-19, Brewing, Walgreens Boots Alliance, Walmart, Woman, Travel, Sam's Club, Management

CHICAGO, Feb. 28, 2024 /PRNewswire/ -- United Airlines Holdings, Inc. (UAL) announced today that Rosalind (Roz) Brewer is joining its Board of Directors.

Key Points: 
  • CHICAGO, Feb. 28, 2024 /PRNewswire/ -- United Airlines Holdings, Inc. (UAL) announced today that Rosalind (Roz) Brewer is joining its Board of Directors.
  • Brewer is an influential leader with CEO experience, repeatedly recognized by Fortune and Forbes among their "Most Powerful Women in Business."
  • "Roz's strategic acumen and visionary leadership make her the right addition to our already strong Board of Directors as we plan for the long-term success of United Airlines," said United CEO Scott Kirby.
  • "I am honored to join the Board of Directors at United Airlines, an iconic company known for its commitment to excellence and innovation in the aviation industry," said Brewer.

Walgreens Boots Alliance to Participate in 44th Annual TD Cowen Health Care Conference

Retrieved on: 
Tuesday, February 13, 2024
Retail, Health, Convenience Store, Other Retail, General Health, Pharmaceutical, EST, Walgreens Boots Alliance, WBA, Conference

Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that Chief Executive Officer, Tim Wentworth, and Global Chief Financial Officer, Manmohan Mahajan, will be presenting at the 44th Annual TD Cowen Health Care Conference, Monday, March 4 at 9:10 a.m. EST.

Key Points: 

Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that Chief Executive Officer, Tim Wentworth, and Global Chief Financial Officer, Manmohan Mahajan, will be presenting at the 44th Annual TD Cowen Health Care Conference, Monday, March 4 at 9:10 a.m. EST.

Petco Names Holly May as Chief Human Resources Officer

Retrieved on: 
Tuesday, February 13, 2024
Pet, SAN, Mental health, EVP, CHRO, Health, Biophysical environment, Visa, Social, Pleasure, ESG, Wellesley College, WBA, Business, Tulane University, Walgreens Boots Alliance, Starbucks, Management

SAN DIEGO, Feb. 13, 2024 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (Nasdaq: WOOF) today announced it has appointed Holly May as Chief Human Resources Officer (CHRO), effective February 4.

Key Points: 
  • SAN DIEGO, Feb. 13, 2024 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (Nasdaq: WOOF) today announced it has appointed Holly May as Chief Human Resources Officer (CHRO), effective February 4.
  • "Holly brings an impressive track record of driving comprehensive HR strategies that align with business objectives and deliver transformational growth.
  • May brings extensive expertise, and two decades of experience in human resources building innovative programs, policies and practices.
  • Prior to joining Petco, May served as EVP & Global Chief Human Resources Officer for Walgreens Boots Alliance (Nasdaq: WBA).

Solera Announces Leadership Transition

Retrieved on: 
Thursday, February 8, 2024
Solera, Walgreens Boots Alliance, Management

PHOENIX, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Solera Health , the premier technology platform for connecting people seamlessly and easily to health solutions that work, today announced a leadership transition as Mary Langowski steps down from the role of Chief Executive Officer and assumes the position of Chairman of the Board.

Key Points: 
  • PHOENIX, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Solera Health , the premier technology platform for connecting people seamlessly and easily to health solutions that work, today announced a leadership transition as Mary Langowski steps down from the role of Chief Executive Officer and assumes the position of Chairman of the Board.
  • Langowski will embark on a new role with Walgreens Boots Alliance, a lead investor in Solera’s 2022 Series D funding round, in March.
  • Her leadership has been instrumental in transforming the company – providing payers and employers the only value-based technology in the market that delivers evidence-based digital condition management solutions in a single, turnkey platform.
  • “Mary’s transformational leadership and focused execution has been critical to Solera’s maturation,” said Matt Downs, who is stepping down from his post as Board Chairman, while remaining a voting member.

Walgreens Boots Alliance Announces Leadership Appointments

Retrieved on: 
Thursday, February 8, 2024
Seniors, Other Retail, Specialty, Convenience Store, Health, Consumer, Pharmaceutical, General Health, Retail, Executive Committee, Pharmacy, Omnichannel, CFO, EVP, CVS Health, Corporate communication, Acquisition, WBA, Culture, Growth, General Electric Company, GE Capital, Biophysical environment, Pharmacist, Public expenditure, State government, Multimedia, Public affairs, CHRO, Hanesbrands, International, Walgreens Boots Alliance, Marketing, Barra, Social, Patient, Management

Walgreens Boots Alliance (Nasdaq: WBA) Chief Executive Officer Tim Wentworth today announced updates to WBA’s Executive Committee as the company advances a health services strategy rooted in its retail pharmacy footprint.

Key Points: 
  • Walgreens Boots Alliance (Nasdaq: WBA) Chief Executive Officer Tim Wentworth today announced updates to WBA’s Executive Committee as the company advances a health services strategy rooted in its retail pharmacy footprint.
  • The spirit of this leadership team is one of collaboration, transparency and working effectively together.
  • Tracey Brown , executive vice president and president, Walgreens retail and chief customer officer
    Brown is responsible for Walgreens $30 billion retail business and consumer experience across all retail, pharmacy and health consumer touchpoints and leads strategies to advance Walgreens across a complex and dynamic competitive landscape.
  • He and his team also play a critical role in aligning and advancing the Walgreens pharmacy and specialty pharmacy businesses across Walgreens, including the U.S. Healthcare business segment.

Cencora Announces Common Share Repurchase From Walgreens Boots Alliance

Retrieved on: 
Wednesday, February 7, 2024
General Health, Finance, Banking, Health, Professional Services, Sale, Treasury, Walgreens Boots Alliance, Share repurchase

Cencora , Inc. (NYSE: COR) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount of approximately $50 million in concurrence with Walgreens Boots Alliance’s sale of Cencora shares pursuant to Rule 144 under the Securities Act of 1933, as amended.

Key Points: 
  • Cencora , Inc. (NYSE: COR) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount of approximately $50 million in concurrence with Walgreens Boots Alliance’s sale of Cencora shares pursuant to Rule 144 under the Securities Act of 1933, as amended.
  • Cencora intends to repurchase shares from Walgreens Boots Alliance at the price per share equal to the price in the Rule 144 sale.
  • The concurrent share repurchase will be made under Cencora’s share repurchase program and the repurchased shares will be held in treasury.